Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
Chang Gon Kim, Chan Kim, Sang Eun Yoon, Kyung Hwan Kim, Seong Jin Choi, Beodeul Kang, Hye Ryun Kim, Su‐Hyung Park, Eui‐Cheol Shin, Yeun‐Yoon Kim, Dae Jung Kim, Hyun Cheol Chung, Hong Jae Chon, Hye Jin Choi, Ho Yeong Lim
Topics & Concepts
NivolumabMedicineRegorafenibSorafenibHepatocellular carcinomaHazard ratioInternal medicineOncologyGastroenterologyProgressive diseaseCohortPlaceboDiseaseImmunotherapyConfidence intervalCancerColorectal cancerPathologyAlternative medicineCancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and PrognosisImmune cells in cancer